http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0045808-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a3e0b688bba1aa04f1c5216fd4c66f28
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0014
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-19
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-19
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K-
filingDate 2000-01-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cc04cbbed5aaea8171f611e2f42a60a7
publicationDate 2000-08-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-0045808-A1
titleOfInvention Preparation for warts
abstract Use of a preparation comprising formic acid as an active ingredient for the manufacture of a medicament for the treatment of skin warts caused by a papilloma virus in a mammal by topical administration on the affected area.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101988693-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2015517570-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/FR-3018687-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2015140690-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10716857-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8658185-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2431030-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2460509-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2692332-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2692332-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8921425-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AU-2012381141-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2013180606-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1450771-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1450771-A4
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2012036616-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3205340-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20150035533-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-03028623-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-03028623-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EA-026621-B1
priorityDate 1999-01-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9817288-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0259617-A2
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID338
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394558

Total number of triples: 40.